Capital International Investors Pacific Biosciences Of California, Inc. Transaction History

Capital International Investors

$504 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$8.23 - $13.93 $9.07 Million - $15.4 Million	-1,102,052 Reduced 26.14%	3,113,749 $26 Million
Q1 2023 May 15, 2023	SELL	$7.94 - $12.02 $15 Million - $22.6 Million	-1,883,880 Reduced 30.88%	4,215,801 $48.8 Million
Q4 2022 Feb 14, 2023	SELL	$5.67 - $11.2 $13.3 Million - $26.3 Million	-2,349,477 Reduced 27.81%	6,099,681 $49.9 Million
Q3 2022 Nov 14, 2022	SELL	$3.93 - $8.57 $12.3 Million - $26.8 Million	-3,126,338 Reduced 27.01%	8,449,158 $49 Million
Q2 2022 Aug 15, 2022	SELL	$4.02 - $10.43 $4.85 Million - $12.6 Million	-1,206,359 Reduced 9.44%	11,575,496 $51.2 Million
Q1 2022 May 16, 2022	BUY	$8.43 - $20.9 $5.69 Million - $14.1 Million	675,537 Added 5.58%	12,781,855 $116 Million
Q4 2021 Feb 14, 2022	BUY	$19.26 - $30.08 $13.7 Million - $21.4 Million	712,191 Added 6.25%	12,106,318 $248 Million
Q3 2021 Nov 15, 2021	BUY	$24.86 - $35.02 $65.1 Million - $91.6 Million	2,616,823 Added 29.81%	11,394,127 $291 Million
Q2 2021 Aug 16, 2021	BUY	$22.3 - $36.02 $18.7 Million - $30.3 Million	840,179 Added 10.59%	8,777,304 $307 Million
Q1 2021 May 14, 2021	SELL	$26.38 - $51.15 $49.4 Million - $95.7 Million	-1,870,901 Reduced 19.08%	7,937,125 $264 Million
Q4 2020 Feb 12, 2021	SELL	$10.5 - $28.5 $9.78 Million - $26.6 Million	-931,806 Reduced 8.68%	9,808,026 $254 Million
Q3 2020 Nov 13, 2020	BUY	$3.61 - $9.87 $14.2 Million - $38.9 Million	3,943,532 Added 58.02%	10,739,832 $106 Million
Q1 2020 May 15, 2020	BUY	$2.36 - $5.26 $3.57 Million - $7.97 Million	1,514,500 Added 28.67%	6,796,300 $20.8 Million
Q4 2019 Feb 18, 2020	BUY	$4.6 - $5.57 $24.3 Million - $29.4 Million	5,281,800 New	5,281,800 $27.1 Million
Q1 2019 May 15, 2019	SELL	$6.8 - $7.4 $14.1 Million - $15.4 Million	-2,080,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$3.99 - $7.82 $8.31 Million - $16.3 Million	-2,082,441 Reduced 50.03%	2,080,000 $15.4 Million
Q3 2018 Nov 14, 2018	BUY	$3.52 - $5.55 $14.7 Million - $23.1 Million	4,162,441 New	4,162,441 $22.5 Million

Others Institutions Holding PACB

# of Institutions

254

Shares Held

228M

Call Options Held

745K

Put Options Held

1.23M

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

33.4M
Shares

$65.1 Million
0.54% of portfolio
Black Rock Inc. New York, NY

23.6M
Shares

$46 Million
0.0% of portfolio
Madrone Advisors, LLC Menlo Park, CA

23.4M
Shares

$45.6 Million
6.35% of portfolio
Edmond De Rothschild Holding S.A. Chambesy, V8

20.3M
Shares

$39.6 Million
0.57% of portfolio
Vanguard Group Inc Valley Forge, PA

17.6M
Shares

$34.4 Million
0.0% of portfolio

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.

Account